Abstract : The ulcerative colitis as well as crohn’s disease is commonly referred to as chronic inflammatory bowel disease. The crohn’s disease affects the terminal ileum or anal canal that is known as terminal ileitis whenever, it involves a part of intestine then, it is called regional ileitis. It involves mostly colon, but may affect whole digestive tract from mouth to anus, if long lasting inflammation and ulcer in digestive tract which affect inner most lining of large intestine (colon) and rectum, While the ulcerative colitis is an inflammatory bowel disease, caused by chronic inflammation and ulcers (sores) in digestive tract and it affects the innermost lining of large intestine such as colon, and rectum. Usually, Infection, Nutritional (food containing sulfur or sulfate), Psychosomatic (depression) and immunological causes help in the development of ulcerative colitis. While conventional treatments can be effective in maintaining remission and decreasing the length of active disease periods. This review article refer to management of UC in the form of dietary changes, appropriate alternative treatment and reduce the extra-intestinal complication.
Keywords : Pathological changes, clinical diagnosis, extra intestinal manifestation.
Cite : Rahman , A., & Irshad, M. (2023). Swertia Chiraita: A Comprehensive Review of its Abundant Medicinal Properties (1st ed., pp. 37-45). Noble Science Press. https://doi.org/10.52458/9789388996983.nsp2023.eb.ch-06
References :
Lightner, A. L., McKenna, N. P., Alsughayer, A., Loftus Jr, E. V., Raffals, L. E., Faubion, W. A., & Moir, C. (2019). Anti-TNF biologic therapy does not increase postoperative morbidity in pediatric Crohn's patients. Journal of pediatric surgery, 54(10), 2162-2165. [PubMed].
Ranasinghe, I. R., & Hsu, R. (2017). Crohn disease.
Greuter, T., Piller, A., Fournier, N., Safroneeva, E., Straumann, A., Biedermann, L. & Swiss IBD Cohort Study Group. (2018). Upper gastrointestinal tract involvement in Crohn’s disease: frequency, risk factors, and disease course. Journal of Crohn's and Colitis, 12(12), 1399-1409. [PubMed]
Chamberlin, W. M., & Naser, S. A. (2006). Integrating theories of the etiology of Crohn's Disease On the etiology of Crohn's Disease: Questioning the Hypotheses. Medical science monitor, 12(2), RA27.
Zaidi, D., & Wine, E. (2018). Regulation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-??) in inflammatory bowel diseases. Frontiers in pediatrics, 6, 317. [PMC free article] [PubMed].
Ephgrave, K. (2007). Extra-intestinal manifestations of Crohn's disease. Surgical Clinics of North America, 87(3), 673-680.
Mendoza, J. L., Lana, R., Taxonera, C., Alba, C., Izquierdo, S., & Díaz-Rubio, M. (2005). Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis. Medicina clinica, 125(8), 297-300.
Basson, M. (2015). Marc Basson.
Gong, S. S., Fan, Y. H., Han, Q. Q., Lv, B., & Xu, Y. (2019). Nested case-control study on risk factors for opportunistic infections in patients with inflammatory bowel disease. World Journal of Gastroenterology, 25(18), 2240. [PubMed]
Mekhjian, H. S., Switz, D. M., Melnyk, C. S., Rankin, G. B., & Brooks, R. K. (1979). Clinical features and natural history of Crohn's disease. Gastroenterology, 77(4), 898-906.
Kathleen Head, N. D., & Jurenka, J. (2004). MT (ASCP). Inlfammatory Bowel Disease Part I2: Crohn’s Disease–Pathophysiology and Conventional and Alternative Treatment Options. Alternative Medicine Review, 360-401.
Freeman, H. J. (2008). Recent developments on the role of Clostridium difficile in inflammatory bowel disease. World Journal of Gastroenterology: WJG, 14(18), 2794.
13.Lichtenstein, G. R., Loftus, E. V., Isaacs, K. L., Regueiro, M. D., Gerson, L. B., & Sands, B. E. (2018). ACG clinical guideline: management of Crohn's disease in adults. Official journal of the American College of Gastroenterology| ACG, 113(4), 481-517.
